Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued
Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued
Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued
Submitted by
admin
on September 12, 2009 - 10:18am
Source:
PR NewsWire
News Tags:
Regeneron
Aflibercept
pancreatic cancer
Headline:
Phase 3 Trial of Aflibercept in Metastatic Pancreatic Cancer Discontinued
Do Not Allow Advertisers to Use My Personal information
